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ARGUMENT
L

MATRIX DID NOT WAIVE ANY ARGUMENTS BY CHOOSING NOT TO
RAISE THEM IN ITS OPENING BRIEF,
Innerlight's brief reads as though there had been a bench trial below. But on

appeal from summary judgment, the reviewing court gives no deference to the trial
court's legal conclusions or factual findings. The standard of review is de novo; this
Court reviews the case anew.
A.

On Summary Judgment, A Trial Court Does Not Find Facts Or Resolve
Factual Disputes.

On appeal from summary judgment, this Court gives no weight or credence to the
trial court's factual findings, since, "by definition, a district court does not resolve issues
of fact at summary judgment. . . ." Poteet v. White, 2006 UT 63, \ 7, 147 P.3d 439, 441
(Utah 2006); see also Ellsworth v. Am. Arbitration Ass % 2006 UT 77, % 19 n.10, 148
P.3d 983, 989 n.10 (Utah 2006) (refusing to give deference to the trial court's findings of
fact on appeal from a summary judgment ruling, then reiterating that on summary
judgment, a trial court errs in finding facts because a trial court "should not resolve
factual disputes").
Further, a reviewing appellate court affords "no . . . deference to the trial court's
legal conclusions . . . . " Wycalls v. Guardian Title, 780 P.2d 821, 824 (Utah Ct. App.
1989); see also Ron Shepherd Ins. v. Shields, 882 P.2d 650, 654 (Utah 1994) ("[W]e do.
not defer to the trial court's rulings

We determine only whether the trial court erred

in applying the governing law and whether the trial court correctly held that there were
not disputed issues of material fact.") (quotations and citation omitted).

Therefore, since this Court reviews the trial court's decision "de novo, reciting all
facts and fair inferences drawn from the record in the light most favorable to the
nonmoving party," the reasoning and rationale behind the trial court's decision is
irrelevant.1 Poteet, 2006 UT 63, f7, 147 P.3d at 441; see also 4 Am. Jur. 2d Appellate
Review § 99 (2008) (uAn appeal cannot be taken from an instrument containing only the
reasons for judgment, but must be taken from the judgment itself"). Matrix had no
obligation to counter each basis for the trial court's decision to preserve any argument on
appeal.
B.

Innerlight's Standard Is Tantamount To A Marshaling Requirement That Is
Neither Necessary Nor Required.

This Court expressly rejected a marshaling requirement for appellants when
appealing from summary judgment: "[w]hen appealing a district court's grant of
summary judgment... the appellant has no obligation to marshal the evidence." Smith v.
Four Corners Mental Health Ctr., Inc., 2003 UT 23, Tf 16 n.6, 70 P.3d 904, 910 n.6 (Utah
2003). Rather, "[t]he marshaling obligation only arises after a party challenges the
sufficiency of the evidence to support a jury's verdict or a district court's ruling
containing specific findings of fact." Id. And since, at the "summary judgment stage, the
district court is not concerned about the sufficiency of any evidence" or findings of fact,
the appellant need not marshal. Id.

1

Innerlight submitted a twenty-one page order, reciting findings of facts and
conclusions of law. (R. at 857-77.) Matrix objected to the proposed order, arguing that
"[s]ince the [trial court] disposed of [the] case on summary judgment, the appellate court
[would] review[] the case de novo." (R. at 804-05.) The trial court overruled the
objection and signed and entered Innerlight's proposed order.

Innerlight's marshaling requirement is not necessary or required when appealing
from a trial court's grant of summary judgment. Therefore, Matrix did not waive any
arguments on appeal by electing not to address them in its opening brief.
C.

When The Trial Court Granted Summary Judgment For Innerlight The
Court Vindicated Innerlight's Sole Cause Of Action.

Innerlight began and ended this case with a thirteen-paragraph complaint and a
single cause of action. It sought a declaratory judgment that "the parties have not entered
into a valid contract. . . ." (R. at 16.) Innerlight then moved for summary judgment on
that single cause of action. (R. at 134-217.) When the trial court granted summary
judgment, it adjudicated Innerlight's single cause of action, declaring that no contract
existed between Innerlight and Matrix. (R. at 857.)
Each and every argument and theory that Innerlight proposed was not a separate
claim or cause of action that Matrix had to address in its opening brief.2 On appeal, this
Court reviews the record as a whole, giving no deference to the trial court or its factual or
legal conclusions. The only issues are whether there is a disputed issue of material fact
and whether the movant is entitled to judgment as a matter of law.
Therefore, since the trial court granted summary judgment as to Innerlight's sole
cause of action, Matrix did not have to address, in its opening brief, every justification for
the trial court's decision to preserve Matrix's ability to counter those arguments on
appeal once Innerlight raised them.
IX

2

Innerlight's Cases Do Not Support Its Conclusion.

Innerlight did not cite a single case for this proposition.

Innerlight's five cited cases do not support its argument that on appeal, Matrix was
obligated, in its opening brief, to address and counter each basis for the trial court's
decision.
1.

Am. Towers v. CCI Mech., Inc., 930 P.2d 1182 (Utah 1996).

First, Innerlight cited Am. Towers v. CCI Mech., Inc. for the proposition that
"[ijssues not briefed by an appellant are deemed waived and abandoned." 930 P.2d 1182,
1185 n.5 (Utah 1996). (Appellee's Br. 13.) In American Towers, the trial court
dismissed some claims against the defendants because they were shareholders of entities
that developed the real estate project at issue, and the court held the corporate veil could
not be pierced. Id. at 1185. The appellant did not address or appeal the dismissal of
these defendants, so this Court, in an attempt at clarity, dropped a footnote and held that
since the appellant did not appeal or address the dismissal of these specific defendants,
the issue was waived. Id. at 1185 n.5. This does not support Innerlight's argument that,
after a trial court grants summary judgment, the appellant must counter, in its opening
brief, each and every argument relied upon by the court.
2.

Coroles v. Sabey, 2003 UT App 339, 79 P.3d 974 (Utah Ct. App.
2003).

Innerlight cited Coroles v. Sabey for the proposition that an appellant must meet
"minimum standards . . . to challenge a trial court's ruling and avoid abandoning any
claim of error." 2003 UT App 339, 79 P.3d 974 (Utah Ct. App. 2003). (Appellee's Br.
13.) Coroles is factually distinguishable. In Coroles, the plaintiffs/appellants brought
thirteen causes of action, and the trial court dismissed the entire complaint. Id. at ^ 6, 9,

979. The plaintiff/appellant presumed to appeal the trial court's ruling with respect to
each of the thirteen individual causes of action. Id. In its opening brief, the appellant
titled section I of the brief "THE TRIAL COURT ERRED IN DISMISSING THE
ENTIRE COMPLAINT." Id. In spite of this broad language, the appellant provided no
analysis in the brief of five of the thirteen causes of action that were supposedly appealed.
Id. On appeal, this Court held that the appellant's global reference alone did not
constitute the analysis required to brief the five causes of action that the appellant all but
ignored. Id.
Contrary to Coroles, Matrix is not briefing only one of Innerlight's several causes
of action. Rather, Innerlight had only one cause of action—a declaratory judgment that
the parties did not execute the Exclusive Distributor Agreement ("Contract"). Innerlight
moved for summary judgment on that single cause of action, and the trial court granted
the motion. Matrix then appealed that ruling on Innerlight's single cause of action.
3.

Pasquin v. Pasquin, 1999 UT App 245, 988 P.2d 1 (Utah Ct. App.
1999).

Innerlight cited Pasquin v. Pasquin for the argument that an appellant "has waived
any challenge to this ruling by failing to raise, brief, or argue the issue." 1999 UT App
245, U 21, 988 P.2d 1, 6 (Utah Ct. App. 1999). (Appellee's Br. 13.) In Pasquin, the court
issued an odd, separate "additional" ruling that the plaintiff could not recover under a
specific cause of action. Id. The plaintiff did not appeal that issue, nor did she "raise,
brief, or argue" it. Id. Therefore, the court of appeals declined to address it.
In the instant case, Matrix followed the letter of the law and raised the only issue it

could—the trial court's ruling on summary judgment which vindicated Innerlight's sole
cause of action. And Innerlight can point to no case, rule, or statute that supports the
marshaling that Innerlight argues for.
4.

Eddy v. Albertson % Inc., 2001 UT 88, 34 P.3d 781 (Utah 2001),
and Coleman v. Stevens, 2000 UT 98,17 P.3d 1122 (Utah 2000).

Innerlight cited Eddy v. Albertson's, Inc. and Coleman v. Stevens for the
proposition that an appellate court "will not consider matters raised for the first time in
the reply brief." Eddy, 2000 UT 98, f 21, 34 P.3d at 785 (citation and quotations
omitted). (Appellee's Br. 15.) In Eddy, the plaintiff requested attorneys' fees—-for the
first time in the entire case—in his appellate reply brief. Id. Clearly, since the trial court
did not have an opportunity to address that issue below, the plaintiff had not preserved
the issue for appeal, and the appellate court could not pass on the issue. Similarly, in
Coleman, the appellant tried to raise issues for the first time on appeal that he did not
raise in the trial court. Coleman, 2000 UT 98,1f9, 17 P.3d at 1124.
Eddy and Coleman present different factual scenarios than the instant case. Both
in the trial court and on appeal, Matrix opposed and contested the trial court's grant of
Innerlight's summary judgment and denial of Matrix's summary judgment. (R. at 90709.) Therefore, Eddy and Coleman are distinguishable and do not apply.
IL

INNERLIGHT FULFILLED THE CONDITION PRECEDENT.
The Contract, executed by the parties, in Section 2(b), did call for Innerlight—not

Matrix—to take the affirmative step of accepting, in writing, the prices of the products it

would purchase from Matrix.3 (R. at 455.) Section 2(b) did not require Innerlight's
written acceptance to take a certain form or to include specific, "magic" language.
Innerlight complied with the condition precedent when it sent six individual,
official purchase orders to Matrix—each purchase order containing the "per unit" price of
each item ordered—totaling more than $250,000 worth of Beverly Sassoon skin care
products. (R. at 462-67.) (Copies of these six purchase orders are attached hereto as
Addendum B.) Innerlight also took "acceptance" of the products' prices a step further by
having one of its employees, Ms. Kathy Christensen, sign each purchase order (r. at 46267), something Section 2(b) did not require (r. at 455). These purchase orders constituted
prima facie fulfillment of Section 2(b) of the Contract—acceptance, in writing, of the
products' prices.
Innerlight argues the legal proposition, without citation to any legal authority, that
purchase orders "are insufficient as a matter of law to constitute an 'acceptance'" of the
products' prices. (Appellee's Br. 21.) This is not a principle of law; rather, it is
Innerlight's conclusory, self-serving interpretation of Section 2(b) of the Contract.
Section 2(b) did not require Innerlight's "acceptance" to take a certain form or to contain
specific language. It required only what it said and nothing more: written acceptance of
the products' prices, and the purchase orders fulfill that requirement.
And as Innerlight's own actions prove, Innerlight and Matrix did agree on the

3

Section 2(b) of the Contract states that "[t]he acceptance of this appointment by
[Innerlight] is conditioned upon [Innerlight's] written acceptance of [Matrix's] Product
Price List which shall not be subject to change until October 17, 2006" (emphasis added).
(A copy of the Contract is attached hereto as Addendum A.)

products5 pricing. (See Section II.A, pp. 19-23, in Appellant's opening brief.) These
actions evidenced Innerlight's belief that it entered into a binding agreement by
performing a laundry list of actions over the eighteen-month life of the Contract, all of
which stemmed from the power granted Innerlight from the Contract.4 Curiously, when

4

These actions include Innerlight: (1) placing exclusive Beverly Sassoon skin care
products on its website for more than a year and a half after the Contract was signed
(through June 2006—months after Innerlight repudiated the Contract), including pictures
of Beverly Sassoon and information touting the benefits of the products (r. at 678)
(Addendum C); (2) publishing a pricelist of the Beverly Sassoon skin care products on its
website (r. at 679); (3) generating several individual purchase orders, each with its own
number, to purchase Beverly Sassoon products from Matrix (r. at 679) (Addendum B);
(4) paying Matrix more than $250,000 for Beverly Sassoon products (r. at 679)
(Addendum D); (5) exercising its option under Section 4 of the Contract by requiring
Beverly Sassoon to appear in Las Vegas to promote Innerlight's exclusive, newly
launched Beverly Sassoon skin care product line (r. at 679) (Addendum E); (6) paying
Defendant $2500 for Sassoon's appearance in Las Vegas pursuant to Section 4 of the
Contract (r. at 679) (Addendum E); (7) paying the travel costs and expenses, pursuant to
Section 4 of the Contract, that were incurred from Sassoon's appearance in Las Vegas (r.
at 679) (Addendum E); (8) exercising its option again under Section 4 of the Contract by
requiring Beverly Sassoon to appear in Newark, New Jersey to promote Innerlight's
exclusive Beverly Sassoon skin care product line (r. at 679) (Addendum F); (9) paying
Matrix $2500 for Sassoon's appearance in Newark, New Jersey pursuant to Section 4 of
the Contract (r. at 679) (Addendum F); (10) issuing press releases from Innerlight's
parent company, The Quigley Corporation, stating that Innerlight had "exclusive" rights
concerning Beverly Sassoon-brand skin care products and that Beverly Sassoon had
become Innerlight's spokesperson (r. at 679) (Addendum G); (11) filing an 8K statement
of its parent company, The Quigley Corporation, with the Securities and Exchange
Commission announcing that The Quigley Corporation had launched an exclusive
Beverly Sassoon skin care product line (r. at 679-80); and (12) filing a 10-Q statement of
The Quigley Corporation with the Securities and Exchange Commission announcing that
it had launched an exclusive skin care line under the Beverly Sassoon brand name (r. at
680) (Addendum H).
Also, for the Court's information, a form 8K is "the 'current report' companies
must file with the SEC to announce major events that shareholders should know about."
U.S. Securities and Exchange Commission, available at
http://www.sec.gov/answers/fonTi8k.htm. And a form 10-Q is a quarterly report
containing information that federal securities laws requires publicly traded companies to

Matrix invoiced Innerlight for Beverly Sassoon's appearances in both Las Vegas and
Newark, Matrix's description on the invoice stated "Beverly Sassoon Appearance Fee—
Per Contract' (emphasis added). (R. at 514.) (Adds. E, F.) Matrix also billed Innerlight
for Ms. Sassoon's hotel stay and her airfare. (R. at 514.) Innerlight paid the total due,
$3548.30, on an Innerlight check, number 64868. (Copies of these documents are
attached hereto as Addendum E.)
Even if the Court were to fine that Innerlight purchase orders did not fulfill
Section 2(b) of the Contract, Innerlight's laundry list of actions support Matrix's
equitable arguments from its opening brief that: (1) Innerlight waived or excused the
condition precedent (Appellant's Opening Br. 23-26); (2) Innerlight ratified the Contract
by reaping its benefits for eighteen months (Appellant's Opening Br. 26-31); and (3)
Innerlight is equitably estopped from denying the existence of the Contract and from
being obligated to its terms and conditions (Appellant's Opening Br. 32-34).
IIL

INNERLIGHT'S UCC ARGUMENTS DO NOT PRECLUDE THE
ENFORCEMENT OF THE CONTRACT'S FORUM SELECTION
CLAUSE,
Innerlight cited to the entire "sales" portion of the Uniform Commercial Code,5

UCC 2-101 to 2-807, to support its argument that this Court should affirm the trial court's
summary judgment rulings. (Appellee's Br. 14.) But for each of Innerlight's citations to

disclose on an ongoing basis, such as unaudited financial statements. U.S. Securities and
Exchange Commission, available at http://www.sec.gov/answers/formlOq.htm.
5
Utah adopted the Uniform Commercial Code and codified it in section 70A-1101 et seq. of the Utah Code. For convenience, throughout this brief, Matrix will refer to
the UCC section (e.g., UCC 2-202(1)), which perfectly corresponds with the Utah Code
section (e.g., Utah Code Ann. § 70A-2-202(l)).

the UCC, there is an exception or a counter-provision that renders Innerlight's UCC
arguments inert and that actually supports Matrix's arguments that the trial court erred in
granting summary judgment to Innerlight and denying summary judgment to Matrix.
A.

The General Application Of The Uniform Commercial Code.

The Uniform Commercial Code, which Utah wholesale adopted, "must be
liberally construed and applied to promote its underlying purposes and policies . . . ."
Utah Code Ann. § 70A-la-103(l). These include simplifying and clarifying the law of
commercial transactions, expanding commercial practices "through custom usage, and
agreement of the parties," and making commercial law more uniform among
jurisdictions. Id. § 70A-la-103(l)(a) to (c). Additionally, principles of law and equity—
including estoppel, ratification, and waiver—supplement the UCC.6 Id. § 70a-la-103(2).
R

UCC Section 2-204(1): Conduct By Both Parties That Recognizes The
Existence Of A Contract Is Sufficient To Show Agreement.

Overriding each and every UCC argument Innerlight makes is the principle that
parties' conduct may recognize and prove the existence of a binding agreement in spite of
the provisions of that agreement. Section 2-204(1) states that "[a] contract for sale of
goods may be made in any manner sufficient to show agreement, including conduct by
both parties which recognizes the existence of such a contract." Utah Code Ann. § 70A-

6

The official comments to the UCC can also be very instructive in applying its
principles. The Utah Court of Appeals has held that the comments to the UCC "are by
far the most useful aids to interpretation and construction, promoting reasonably unifonn
interpretation of the code by the courts." Power Sys. & Controls, Inc. v. Keith's Elec.
Constr. Co., 765 P.2d 5, 11 n.3 (Utah Ct. App. 1988) (citation and quotations omitted).
Therefore, where appropriate and instructive, Matrix cites to the UCC's Official
Comments.

2-204(1) (emphasis added). The Official Comment to this section clarifies and endorses
this idea: "appropriate conduct by the parties may be sufficient to establish an
agreement."
In this case, the parties' conduct—particularly Innerlight's twelve discrete actions
described in footnote 4 supra—evidence their recognition and endorsement of the
Contract. Innerlight performed under the Contract for eighteen months and reaped the
benefits of the Contract for that duration. Innerlight issued press releases (Add. G), made
SEC filings (Adds. H, I), advertised and sold the products (Adds. C, D), and even secured
and paid for Beverly Sassoon to appear—twice—to promote the products (Adds. E, F).
Innerlight could not have done any of these acts without the Contract.
Section 2-204(1) allows parties' conduct to evidence their recognition of an
agreement for the sale of goods. Innerlight's and Matrix's conduct for a year and a half
evidenced their understanding, belief, and intent that the Contract was in effect.
C.

UCC Section 2-305(4): The Parties Fixed The Products' Prices.

Throughout its brief, Innerlight makes sporadic reference to UCC section 2-305(4)
as justification for the trial court finding that no contract existed. (Appellee's Br. 7, 15,
16, 24, 29.) In relevant part, section 2-305(4) provides that where "parties intend not to
be bound unless the price be fixed or agreed and it is not fixed or agreed there is no
contract." Utah Code Ann. § 70A-2-305(4).
The syllogism, Matrix assumes, goes like this: (1) based on Section 2(b) of the
Contract, Matrix and Innerlight did not intend to be bound unless the products' prices
were fixed; (2) Matrix and Innerlight never fixed the prices; therefore (3) there is no

contract.
The flaw in InnerHght's argument lies in point number two. Contrary to
Innerlight's unfounded claim, the parties actually fixed the prices when the principals of
Matrix and Innerlight negotiated and decided upon the products' prices (discussed in
Section II.A, p. 20, in Appellant's Opening Brief), which is evidenced by Innerlight's
several purchase orders containing the per unit prices of each product. (R. at 462-67.)
These per unit prices were the same prices that Matrix and Innerlight fixed before signing
the Contract. (R. at 676.) Therefore, UCC 2-305(4) is not a bar to enforcing the forum
selection clause in the Contract.
a

UCC Section 2-202(1): InnerHght's Purchase Orders Are Not "Evidence Of
Any Prior Agreement Or Of A Contemporaneous Oral Agreement."

Next, Innerlight argues that UCC section 2-202(1) precludes Matrix from using
InnerHght's purchase orders as evidence that the parties fixed the products' prices
because the prices in the purchase orders, Innerlight argues, contradict the terms of the
Contract. (Appellee's Br. 20.) But section 2-202(1), by its own terms, applies only if a
party tries to use a prior or contemporaneous agreement to alter the terms of an original
agreement, which Matrix is not doing here. Section 2(b) of the Contract called for
Innerlight, via documentation other than the Contract itself, to accept, in writing, the
products' prices, which Innerlight did through its several purchase orders listing the per
unit price for each item. Thus, Innerlight did exactly what Section 2(b) of the Contract

Innerlight implies that Section 2(b) of the Contract required Matrix to submit a
company price list before Innerlight could provide written acceptance of the products'
prices. (Appellee's Br. 26 n.9.) But this alleged requirement is fictional. Section 2(b)

demanded.
Section 2-202(1) states, in relevant part:
Terms with respect to which the confirmatory memoranda of the
parties agree or which are otherwise set forth in a writing intended
by the parties as a final expression of their agreement with respect to
such terms as are included therein may not be contradicted by
evidence of any prior agreement or of a contemporaneous oral
agreement....
In this case, Matrix is not attempting to contradict the terms of the Contract by
looking to Innerlight's purchase orders as evidence of Matrix and Innerlight fixing the
prices. Rather, Section 2(b) specifically mandated Innerlight to accept, in writing, the
products' prices, and Innerlight had to do that via documentation other than the Contract
itself. It is impossible not to refer to some other documentation as evidence that
Innerlight fulfilled Section 2(b), and in this case, we look to Innerlight's purchase orders.
Moreover, Innerlight's argument does not work because its purchase orders do not
contradict any provision in the Contract. In fact, the Contract specifically required the
parties to look to some other documentation as evidence of the products' prices.
Innerlight's argument would apply only if the Contract itself recited the products' prices,
and Matrix then tried to use Innerlight's purchase orders to contradict the prices
established in the Contract. But that is not the case.
Additionally, even if section 2-202 applied to bar Matrix's reference to
Innerlight's purchase orders as fulfillment of Section 2(b) of the Contract, subsections (1)
and (2) of section 2-202 provide exceptions to the rule by allowing the parties' course of
puts the onus on Innerlight, not Matrix, to accept the products' prices, which Innerlight
did via its purchase orders.

performance, and consistent additional terms, to supplement and explain the Contract.
1.

Section 2-202(1) allows the parties5 "course of performance55 to
supplement and explain the terms of the Contract.

Contrary to Innerlight's assertions, subsection (1) of 2-202 allows parties' "course
of performance" to explain or supplement a contract. In this case, that means Innerlight's
purchase orders, as well as Innerlight reaping the benefits of the Contract for a year and a
half, evidenced that Innerlight accepted the products' prices.
Subsection (1) of 2-202 states that terms of a contract "may not be contradicted by
evidence of any prior agreement or of a contemporaneous oral agreement but may be
explained or supplemented . . . by course of performance (Section 70a-2-208) . . . ." Utah
Code Ann. § 70A-2-202 (emphases added).
The "course of performance" statute referred to above, section 70A-2-208,
o

establishes what "course of performance" means and how it operates. Subsection (1) of
2-208 states that
[wjhere the contract for sale involves repeated occasions for performance
by either party with knowledge of the nature of the performance and
opportunity for objection to it by the other, any course of performance
accepted or acquiesced in without objection shall be relevant to determine
the meaning of the agreement.
The next subsection of 2-208, subsection (2), provides that the express terms of the
Section 2-208, the "course of performance" exception, is also known as the "rule
of practical construction." Utah Code Ann. § 70A-2-208. This rule "is predicated on the
common sense concept that actions speak louder than words," and this Court adopted the
rule in 1965 with Bullough v. Sims, 400 P.2d 20, 23 (Utah 1965) (citations and quotations
omitted). The Restatement of Contracts, section 235, defines the Rule as follows: "If the
conduct of the parties subsequent to a manifestation of intention indicates that all of the
parties placed a particular interpretation upon it, that meaning is adopted if a reasonable
person could attach it to the manifestation."

agreement and any course of performance "shall be construed whenever reasonable as
consistent with each other

" Utah Code Ann. § 70A-2-208(2).

Taken together, then, 2-208(1) and (2) establish an exception to 2-202 which
generally does not allow the parties' conduct to alter or explain their agreement. The 2208 exception looks to the parties' course of performance to explain and clarify the
meaning of the parties' agreement, so long as the agreement calls for repeated occasions
for performance. And any course of performance must be construed as consistent with
the terms of the agreement.
The Contract between Innerlight and Matrix involved repeated occasions for
performance, which, in this case was not limited to Innerlight issuing six separate
purchase orders for more than $250,000 worth of Matrix's products. In addition to the
purchase orders, Innerlight also performed under the Contract for eighteen months in
numerous and varied ways by, inter alia, twice procuring Beverly Sassoon to appear and
promote Innerlight's products (r. at 679), advertising and selling the products on its
website (r. at 678-79), issuing multiple press releases about the Contract (r. at 678-80),
and making SEC filings based on its Contract with Matrix (r. at 679-80).
Construing Innerlight's performance as consistent with Section 2(b) of the
Contract (as 2-208(2) requires), it becomes evident that Innerlight intended to accept—
and in fact did accept—the products' prices.
2.

Section 2-202(2) allows the Court to consider Innerlight's
purchase orders as "consistent additional terms" with the
Contract.

Subsection (2) of 2-202 provides another exception, besides the "course of

performance" exception, that operates to "explain[] or supplement^' the terms of a
contract. Subsection (2) says that terms of a contract may be explained or supplemented
by evidence of consistent additional terms, provided the agreement is not a complete
statement of the terms of the agreement. In this case, the Contract is not an exclusive and
complete statement of the terms between Innerlight and Matrix because Section 2(b)
demanded that Innerlight accept the products' prices in a separate document. Therefore,
the per unit prices in Innerlight5s purchase orders fall under subsection (2) and may
explain or supplement the terms of the Contract, specifically, Section 2(b).
Subsection (2) of 2-202 states, in relevant part, that terms of a contract
may not be contradicted by evidence of any prior agreement or of a
contemporaneous oral agreement but may be explained or supplemented:
. . . (2) by evidence of consistent additional terms unless the court finds the
writing to have been intended also as a complete and exclusive statement of
the terms of the agreement.
In this case, Innerlight5s purchase orders fall squarely within the definition of
"consistent additional terms" because Section 2(b) requires Innerlight to accept the
products' prices via documentation other than the Contract. The several purchase orders
constitute the documentation required by Section 2(b), and moreover, they are consistent
with the terms of the Contract. Therefore, the Court should read the purchase orders as
explaining and supplementing the Contract, specifically, Section 2(b).
Innerlight may argue that the Court should not allow the purchase orders to
explain or supplement the Contract as "consistent additional terms" because the Contract
is "a complete and exclusive statement of the terms of the agreement." But Section 2(b)
belies that argument. That section explicitly requires the parties to look to some other

documentation, some other evidence, that Innerlight agreed to the products' prices.
Therefore, the Contract was not the "complete and exclusive" statement of the parties'
agreement—the price term, an integral part of any contract, was omitted, and the Contract
specifically directed the parties to some other documentation for evidence of the
products' prices.
Therefore, this Court should look to Innerlight's purchase orders as evidence of
consistent additional terms to explain and supplement the Contract.
K

UCC Section 2-208(3): The Parties' "Course Of Performance" Can Show
Waiver Or Modification Of Any Term In The Contract, Including Section
2(b) And The Anti-waiver Clause.

Innerlight argues that it did not waive the condition precedent in Section 2(b) or
the anti-waiver clause in Section 12 of the Contract. (Appellee's Br. 10, 28-34.) But
section 2-208(3) states that course of performance is "relevant to show a waiver or
modification of any term inconsistent with such course of performance."10
A waiver is "the intentional relinquishment of a known right." Soter's, Inc. v.
Deseret Fed. Sav. & Loan Ass % 857 P.2d 935, 940 (Utah 1993) (citation and quotation
omitted). There are three elements to show waiver: "(1) an existing right, benefit, or
advantage; (2) knowledge of its existence; and (3) an intention to relinquish the right."
Id. A waiver must be distinctly made, though it may be express or implied. Id.
9

Official Comment 1 to UCC 2-201 explains that "[i]n many valid contracts for
sale the parties do not mention the price in express t e r m s . . . . [Frequently the prices is
not mentioned since the parties have based their agreement on a price list or catalogue
known to both of them and this list serves as an efficient safeguard against perjury."
10
The Official Comment to the UCC also adds that "[u]nder this section a course
of performance is always relevant to determine the meaning of the agreement" (emphasis
added).

Innerlight met each of these elements and either expressly or impliedly waived the
condition precedent and the anti-waiver clause.
First, Innerlight waived the condition precedent, and all three elements for waiver
are met: (1) Section 2(b) of the Contract was a right, benefit, or advantage for Innerlight;
(2) Innerlight knew about Section 2(b) of the Contract (Section 12 of the Contract also
states each party had the assistance of counsel in reviewing and signing the Contract);
and (3) Innerlight's twelve discrete, undisputed actions make clear that Innerlight
intended to relinquish the right in Section 2(b) and the anti-waiver provision in Section
12 because Innerlight performed under the Contract for a year and a half.11
Second, Innerlight also waived the anti-waiver clause in Section 12 of the Contract
by continuing to perform under the Contract for eighteen months (r. at 459). Although
initially counterintuitive, for more than sixty years, this Court's jurisprudence has held
that a party may waive an anti-waiver clause. Living Scriptures, Inc. v. Kudlik, 890 P.2d
7, 10 n.3 (Utah Ct. App. 1995) (citing, inter alia, Calhoun v. Universal Credit Co., 146
P.2d 284, 286 (Utah 1944)) ("[CJourts have concluded that [nonwaiver provisions] may
be waived."); see also 1 White and Summers, Uniform Commercial Code, 4th Ed. §§ 1-6,
p.41-42 (u[P]arties may . . . provide that no waiver shall bind unless in writing. This
clause itself may be waived .. ."). More recently, in State v. Pena, this Court
acknowledged that over time, it had "developed hopelessly inconsistent elaborations on
1]

Moreover, an anti-waiver clause in a contract does not, by itself, prevent a party
from waiving any provision in the contract. Living Scriptures, Inc. v. Kudlik, 890 P.2d 7,
10 n.3 (Utah Ct. App. 1995) (concluding that "the best approach is to view the existence
of an anti-waiver provision as merely one factor to consider in determining whether a
party has waived its right under the agreement").

the basic statement of waiver principles." 869 P.2d 932, 938 (Utah 1994) (citation
omitted) (referring to both civil and criminal examples). In light of the confusion, the
Court "stripped the statement of the law back to its most basic form and told the trial
courts to apply it." Id. (citation omitted).
Therefore, whether Innerlight waived the anti-waiver clause in Section 12 is
analytically no different than the question of whether Innerlight waived any other
provision of the Contract. Rather, the question of waiver of any clause "is a highly factdependent question" that must be determined ad hoc. Pena, 869 P.2d at 938.
Innerlight's course of performance, and its exercise of rights that stemmed only
from the Contract, were so pervasive that one must conclude that Innerlight explicitly or
implicitly waived both Section 2(b) and the anti-waiver clause in Section 12.
R

UCC Section 2-209(5): Innerlight Failed To Timely Rescind Its Waiver.

Innerlight next argues that even if it did waive Section 2(b) and the anti-waiver
provision, it timely rescinded the waivers under section 2-209(5). (Appellee's Br. 10,
29.) But Innerlight's alleged rescission was not timely, reasonable, or just. Further,
Innerlight failed to comply with the terms of 2-209(5), which required Innerlight to
provide reasonable notification to Matrix that Innerlight would expect strict compliance
with the Contract.
Section 2-209(5) allows a party to retract a waiver, but only if the retracting party
meets certain conditions:
[a] party who has made a waiver affecting an executory portion of the
contract may retract the waiver by reasonable notification received by the
other party that strict performance will be required of any term waived,

unless the retraction would be unjust in view of a material change of
position in reliance on the waiver.
To comply with section 2-209(5), Innerlight had to (1) provide reasonable
notification to Matrix, (2) ensure that Matrix received the notification, and (3) convey
that strict performance would be required of the waived terms (Section 2(b) and the antiwaiver clause).
After reaping the benefits of the Contract for eighteen months, Innerlight notified
Matrix that Innerlight deemed the Contract invalid and that Innerlight would no longer be
selling Beverly Sassoon products. (R. at 528, 534.) Innerlight failed to convey, however,
that strict performance with Section 2(b) and the anti-waiver provision would be
required, which section 2-209(5) demands. Rather, Innerlight merely stated that "it is
[Innerlight's] belief that the Contract was never accepted." (R. at 528.)
Moreover, even if Innerlight met the three requirements in 2-209(5), which it did
not, that section precludes retraction if it would be unjust in view of a material change of
position in reliance on the waivers. In this case, retraction would be unjust because
Matrix materially changed its position in reliance on Innerlight's waivers of Section 2(b)
and the anti-waiver clause. Most notably, Matrix forwent offering the exclusive
distributorship to another entity. The Contract's recitals state that Innerlight "desires to
be the exclusive distributor of certain of [Matrix's] BEVERLY SASSOON brand name
products. . . and [Matrix] is willing to make [Innerlight] its exclusive distributor for such
purposes. . .." (R. at 454.) The exclusive distributorship would have gone to another
entity but for Innerlight signing the Contract (r. at 460) and acting pursuant to it for a year

and a half. Matrix could have only one exclusive distributor. Innerlight acted as if it
was, so Matrix was powerless to change this.
IV.

THE TRIAL COURT INCORRECTLY RULED ON THE PARTIES9
MOTIONS TO STRIKE EACH OTHER'S AFFIDAVITS.
A.

Tate's Affidavit Contains Inadmissible Hearsay, So The Trial Court Should
Have Stricken The Offending Paragraph.

Paragraph thirteen of Wesley Tate's Affidavit (r. at 171-73) contains inadmissible
hearsay. This Court should reverse the trial court and strike the offending paragraph. (A
copy of the trial court's order, r. at 878-79, is attached hereto as Addendum I.)
Rule 801(c) of the Utah Rules of Evidence defines hearsay as "a statement, other
than one made by the declarant while testifying at the trial or hearing, offered in evidence
to prove the truth of the matter asserted." Rule 802 goes on to exclude hearsay evidence
except as provided by the rules of evidence.
Paragraph thirteen of Tate's affidavit states: "Following the sale of certain
Sassoon products purchased from Matrix, Innerlight received complaints from customers
including, [sic] that a facial product caused 'burning' to the customer's skin, that a lotion
was 'runny,' and that lotion pumps were inoperable." (R. at 191.)
These statements are out-of-court statements offered for their truth, i.e., that
Innerlight received complaints that the Beverly Sassoon skin care products caused
"burning" or were "runny." Innerlight does not contest this—it admitted that Tate made
these statements to show that "Innerlight had 'received complaints'" about the products.
(Appellee's Br. 40.) Therefore, the statement is hearsay, no exception applies, and the
Court should exclude it under Rule 802 of the Utah Rules of Evidence.

B.

The Trial Court Erred In Striking Catinella's Third Affidavit.
1.

Matrix opposed Innerlight's Motion to Strike.

Innerlight argues Matrix "did not oppose [Innerlight's Motion to Strike]," and that
Matrix filed "an untimely opposition to Innerlight's motion the day after the motion was
decided," and therefore, the trial court was correct to grant Innerlight's motion to strike.
(Appellee's Br. 40.) This is both misleading and incorrect.
In late 2006, Matrix and Innerlight both filed motions for summary judgment and
the accompanying affidavits. On September 29, 2006, Matrix filed its Motion to Strike
Portions of Tate's Affidavit (which Innerlight had filed in support of its Motion for
Summary Judgment). (R. at 411-17.) Then, on November 28, 2006, the trial court filed a
Notice of Oral Argument. (R. at 735-37.) (A copy of this Notice is attached hereto as
Addendum J.) The Notice stated that the Court would hear argument on January 17,
2007 on three (and only three) motions: (1) Innerlight's Motion for Summary Judgment;
(2) Matrix's Motion for Summary Judgment; and (3) Matrix's Motion to Strike Portions
of Tate's Affidavit. (R. at 735.) (Add. J.)
On January 4, 2007—two weeks before oral argument on the three motions above
and a month and a half after the court sent the notice or oral argument—Innerlight filed
its Motion to Strike Portions of the Third Affidavit of Anthony R. Catinella. (R. at 74143, 758-63.) Under Rule 6(a) (ten filing days excludes weekends) and Rule 7(c)(1) (must
file an opposition to a motion within ten days) of the Utah Rules of Civil Procedure,
Matrix had at least until January 18, 2007 to file its opposition. And Matrix filed its

opposition on January 16, 2007 .

(R. at 779.)

Innerlight's motion to strike was never noticed for argument during the January
hearing. Further, even if Innerlight's motion to strike had been noticed for argument at
the January 17 hearing, Matrix could not submit Innerlight's motion for decision because
the briefing time had not expired under Rule 7(c)(1). And even if the parties stipulated to
jointly submit Innerlight's motion to strike at the hearing (in spite of the above defects),
the trial court incorrectly concluded that Matrix's opposition was untimely filed, since
Matrix filed its opposition on January 16, the day before the hearing. (R. at 779.)
2.

Matrix timely filed Catinella's third affidavit in conjunction
with Matrix's reply memorandum in support of summary
judgment

Innerlight argues that the trial court properly struck Catinella's third affidavit (r. at
703-20) "because it was untimely." (Appellee's Br. 41.) But Rule 56(e), which
specifically speaks to the use of affidavits with summary judgment motions, states that
"[t]he court may permit affidavits to be supplemented or opposed by . . . further
affidavits." Indeed, it is the responsibility of each party, when moving for and opposing
summary judgment, to submit affidavits so that the trial court may determine if there
exists a genuine issue of material fact that would preclude granting the motion. Utah R.
Civ. P. 56(c). There is no rule or case law that renders an affidavit filed with a reply
memorandum "untimely."
Innerlight cites Sunridge Dev. Corp, v. RB&G Eng'g, Inc., 2008 UT App 29, f9

12

Rule 5(b)(1)(B) of the Utah Rules of Civil Procedure states that "[s]ervice by
mail... is complete upon sending."

n.4, 177 P.3d 644, 647 n.4 (Utah Ct. App. 2008), for the proposition that an untimely
affidavit is "subject to exclusion ceven if the results lead to a grant of summary judgment
against the party seeking its introduction.5" (Appellee's Br. 41) (quoting Sunridge Dev.,
2008 UT App 29, | 9 n.4, 177 P.3d at 647 n.4). But that case is inapposite. There, the
plaintiffs/appellants failed to timely submit a damages affidavit. Sunridge, 2008 UT App
29, f9, 177 P.3d at 646-47. In this case, Matrix submitted an additional affidavit in
support of its Motion for Summary Judgment with its reply memorandum. There is no
rule or prohibition against such a submission or that makes the affidavit "untimely."
3.

Catinella's third affidavit complies with Rule 56(e), is based on
personal knowledge, and contains no hearsay.

Finally, Innerlight argues that paragraphs 3 and 8-14 of Catinella's third affidavit
should be excluded because they are not based on personal knowledge and they are
conclusory. (Appellee's Br. 41-45.) Each of Catinella's statements in these paragraphs is
based on his personal knowledge and understanding of the history of events in this case.
Admittedly, Catinella's recollection and understanding of this history may differ from
Innerlight's recollection and affidavits, but that merely justifies the court in denying
summary judgment, not in striking the affidavit.
For example, Innerlight argues that Catinella's statement that the parties "agreed
upon the prices at which [Innerlight] would sell" the products is a legal conclusion.
(Appellee's Br. 42.) With this statement, Catinella merely recites his lay understanding
of his negotiations and conversations with the principals of Innerlight. Nothing in his
statement purports to convey what Innerlight or its principles believed or a legal

•J o

conclusion.
V.

PURSUANT TO RULE 24(a)(9), MATRIX REQUESTS ATTORNEYS9
FEES AND COSTS ON APPEAL BASED ON SECTION 12 OF THE
CONTRACT.
Rule 24(a)(9) of the Utah Rules of Appellate Procedure requires that "[a] party

seeking to recover attorney's fees on appeal shall state the request explicitly and set forth
the legal basis for such an award." Pursuant to that rule, Matrix hereby explicitly
requests attorneys' fees and costs on appeal based on Section 12 of the Contract14 and
based on Utah law that allows for attorneys' fees when provided for in a contract.
Stewart v. Utah Pub. Serv. Comm 7i, 885 P.2d 759, 782 (Utah 1994) ("[Attorney fees
cannot be recovered unless authorized by statute or contract.").
CONCLUSION
Innerlight cannot revise history to disown its clear belief and intent to abide by the
Contract after abiding by its terms for eighteen months, all while reaping the Contract's
benefits. This Court should reverse the trial court and grant summary judgment for
Matrix, thereby enforcing the forum selection clause and sending the parties to Florida to
litigate. In the alternative, based on many disputed issues of material facts, and viewing
the facts in a light most favorable to Matrix, the Court should reverse the grant of
summary judgment for Innerlight and remand to the trial court.
13

Without reciting each of the eight disputed paragraphs and independently
analyzing each paragraph, the argument above applies to each of the disputed paragraphs.
Catinella repeatedly recites precisely what the Contract stated (r. at 703-07,ffl[3, 12) and
the factual history of the parties' discussions and negotiations (r. at 705, ^ 8-14).
14
Section 12 of the Contract allows the prevailing party in litigation concerning
the Contract to received attorneys' fees and costs, including for "any and all appeals
. . . . " (R. at 459.)

RESPECTFULLY SUBMITTED this 7th day of May 2008.

HILL, JOHNSON & SCHMUTZ, L.C.

Stephen Quesenberry
Charles L. Perscnbn
Attorneys for Defendant/Appellant
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EXCLUSrVE DIETRfftUTOn AGREEMENT

THIS EXCLUSrVE DISTRIBUTOR AGREEMENT is made rind entered into as of* the
day of
. 2004. between THE MATRIX GROUP, LLC ("Company"),
and INNERLIGHT, INC. ("Distributor11).
WITNESSETH
WHEREAS, Company is licensed to sell products under the brand name "BEVERLY
SASSOOK'11 ihroughoui ihc world; and
WHEREAS, Distributor desires to be the exclusive distributor of certain of Company's
BEVERLY SASSOOK brand name products in the multi-level marketing/network marketing
industry within (he territory morc particularly described below, and Company'is willing to make
Distributor iLs exclusive distributor for such purposes, all in accordance with and pursuant in (he
terms and conditions more fully scl forth below;
NOW, THEREFORE, in consideration of Lhe above, the mutual covenants and agreements
sd forth herein, and other good and valuable consideration, ihc receipt and sufficiency of which are
hereby acknowledged, ihc parties hereto do hereby agree 85 follows;
1,

Company Rcprcssntoiionsand Warranties.

The Company hereby represents and warrants lo Distributor as follows;
(a)

ThBl Lhe Company:

(i)
has a license lo utilize (he BEVERLY SASSOON name on, among
olhcr things, ihc Company's cosmetics, cosmasculjculs, nutrasculicsls, canning,
make-up, vhamins, bahy-products ond pet products; and
(ii)
such license h for n slated-term at least as long as the term of this
Agreement; and
(ii/)
the aforesaid license is in full force and cflfcel and Company is nol in
default thereunder;'and
(iv)
Company will keep said license in effect for the full term of this
Agreement; and
(b)
That in connection with the License A&rccmcnl for the BEVERLY
SASSOON name with Bc\>cr)y Saloon International, LLC ("Licensor"), lhe Licensor has
warranted thai it has rhc rights lo the BEVERLY 5ASSOON name and thai it wjlJ indemnify
Company frnm nil los.icn. claims, damages, owards, penalties and injuries which may nri3c in
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conncciion with any claim by ii/ty ihf rd parly of any Alleged infringement ofcypyri^hl, Iradcm/irk or
other intellectual propertyrightspertaining (o the use nft/ie BEV'EftLY SASSOON niunc; and
(c)
Thut in fhe event /iny party makes any claim for Ihc infringement of
copyright, trudcrn/irk or ofher inlcllecluul properly rights concerning (he use of ihc BEVERLY
SASSOON brand name in connection with any of (he Producis (as defined below), Company will,
promptly following its receipt of notice of such claim from Distributor, cidl upon Licensor (o
provide (he indemnifications net/ui red under (he License Agreement between. Ihc Company and ihc
Licensor and thai Com/winy will hold Distributor harmless from all losses, claims, damages, awards,
penal lies or injuries arising ou( of such infringement claims.
2.

Appointment ofDislribulor.

(H)
Subjccl to the term* nod provisions sti forth in this Agreement, Company
hereby appoints Distributor as the exclusive distributor for the Products (defined below) within the
Territory (defined below) insofar 05, but only insofar as, Lhe Industry (defined below) is concerned,
As used herein, ihc term "rYodacts" she!! mean the Company's cosmetics, cosmascuticals,
niitrasfuricals, tanning, make-up, vitamins, baby-products and pet products from time 10 time
bearing the BEVERLY SASSOON ruunt. As used herein, (he term "Territory" shall include aJI
worldwide markets, including the United Stales, except for Asia (Asio is expressly excluded from
Ihc Territor)'). .As .used herein, the term "Industry1' shall mean the multi-level marketing and
network marketing; industries. Company expressly agrees that it will not sell Product5 bearing (he
BEVERLY SASSOON name -within the Territory to any other party operating within Ihc Indusiry
and that Company wiJI not itself-engage in (he Industry 10 sell 'Products bearing the BEVERLY
SASSOON name on a multi-level marketing/network marketing basis. It is cxprcss)y understood
and agreed, however, not by way of limitation, thai the Company-may sell BEVERLY SASSOON
branded -prodacts or-services other than ihc'Products ID any other parties of its choosing, and thai
Company may sell Producis bcarintJ the BEVERLY SASSOON name in any other parties of its
choaring who are not involved in the Industry, in any market (world wide, regional,, local or other),
•whether on a retail, wholesale or any other basis, and that Company may sell Products bearing the
BEVERLY SASSOON name to companies engaged in the -Industry within the continent or Asia, alt
without being in violation of this Agr&cmcnl.
(b)
The acceptance of (his appointment by Distributor is conditioned upon
Distributor's v\Titte/) acceptance of Company's 'Product Price List which shall not be subject to
change until October I 7, '2006.
J.

Term,

Subject to ihc termination rights elsewhere set forth in this Agreement, the term of this
Agreement shall commence as of the dnte first set forth above md shall end nn October 17, 2013,
A.II obligations of the Company and all rights of Distributor shall ccaj;c and terminate ot the end of
the aforesaid term and die Company shall thereafter be under no restrictions insofar as the sole of
Products is concerned.
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(ii)
notwithstanding lhc rorc^omg, Distributor must purchase an amount of
Products from Campuny each qunricf year period (i.e., uuch October 1flthrough ench
January 17, and each January IS through each April 17, m\d each April IX through July 17,
und each July IX through October 17 during each of .inch yean) equal to one-quarter of the
Minimum Purchase Requirement Amount applicable to the yaw in question, with payment
to be received by Company prior to (he end of each such applicable quarter
6,

Ltrriiuumns and Prohibitions on Distributor,

It is understood *nd agreed thai
(a)
Distributor shall not have or Acquire nny rights to any patents, trademarks,
serYiccrruirks, trade sccmls or nny olhcr intellectual properly rinhts relating in any manner to any of
the Products or in or to the name of BEVERLY SASSOON.
(b)
Distributor shall have no rights to use the name BEVERLY SASSOON on
any product olhcr Jhan Lhc Products. It is cxpirs^Jy understood and agreed that Distributor has no
rights to use the name BEVERLY SASSOON on "Human Hair Care" relBlcd products as such
•would violate the terms of Company's license with Licensor.
(c)
Distributor shall make no claims of health benefits, other benefits, or results
customers could anticipate receiving from BEVERLY SASSOON Products unless such claims arc
•expressly authorized in writing by Company or are contained on labels or other sales materials
•provided by Company. Distributor shall no! make any claims concerning the Products, or
concerning the BEVERLY SASSOON name, or concerning Beverly Sassoon the. person without
first receiving the prior written authorization to do so From Company which approval may bc.givcn
or withheld within the sole discretion of Company.
(d)
Distributor shall no( repackage any Product, remove art)' label or other
identifying marking from any Product, or otherwise alter any packaging or label of any Product al
any time. Distributor shall -not tamper whh< alter, modify, change or otherwise afTect any Produce
sold to il by Company,
(e)
Distributor shall no! sell, produce, manufacture or otherwise be involved in or
with respect to any goods or products similar (o or in competition in any way with any of the
Products during the term of this Agreement.
(F)
Distributor shall comply wj(h oil Inwss stiihiics, rain and regulations of any
and all governmental authorises having jurisdiction over its business opcrnt ions.
(£.)
Distributor 'ihtill market and act I the Products, and authorize her distributors
to market and sell the Products, only within the Industry and only within the Territory. Neither
Distributor nor any party acquiring (he Products through Distributor shall sell Lhc Products olhcr
than rh rough the multi-level marketing/network marketing channels.
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Disclaimers,

Except as expressly scl forth herein, Company makes no representations or warrantic;, to

Distributor, cither ex-press or implied. SPECIFICALLY, BUT NOT 8Y WAY OF LIMITATION,
COMPANY DISCLAIMS ALL WARRANTIES OF MERCHANTABILITY AND/OR FITNESS
FOR. A PARTICULAR PURPOSE (N RESPECT OF THE PRODUCTS
R.

Default,

(n)
The occurrence at-any of Lhc following cvcnLs shall constitute an Even! of
Default by Distributor under this Agreement:
(l)
Distributor sruJI fail ID sntisfy any Minimum Purchase Requirement it
is obligated lo comply with pursuant to the provisions of (his Agreement or
Distributor shall otherwise fail lopBy to Company any amount which Distributor is
obligated to pay Lo Company;
(ii)

Distributor shall brach or fail to perform any other duty, obligation

oragrccmcnl on Distributor's pnri to be complied with or performed pursuant to this

Agreement and Distributor shall have failed to satisfy or curt such default within ten
(10) days after the giving of written notice of such default lo Distributor by
Company; or
(lit)
Distributor shall be or become the subject of any bankruptcy or
insolvency proceedings.
(b)
Upon the occurrence of-any Event of Default, Company may exercise any
one or more of Ihc following rights and remedies, afl of which shall be mutual and cumulativc.and
no! exclusive:

(i)

Terminate this Agreement by giving written notice or such

termination to Distributor; And/or

(ii)
Have and recover from Distributor all damages suffered by Company
by reason of the occurrence ofsuch Even! of Default together with all reasonable attorneys
fees and disburseTncnts expended or mcurml by Company in enforcing or pursuing

lis rights

under this Agreement; and/or
(iii)

Pursue any other rights or remedies tiYuilqbk to the Company a( law

or in equity.
9,

Relation.ship,

Nothing contained in ihis Agreement shall be construed as constituting a joint
venture^ partnership, employer/employee rctntionship, franchise DJ other a^ocialjon between the
parties hereto. Distributor is acting only in the capacity of an indcpcndcni contractor a n d shall hxtvc
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no authority, express or implied, lo hind, oblijLjnjc or make any commitment or representation for of
on behalf of Company.
10.
Notices,
Any notice required or permitted lo be p.i^cn by any party Lo the other under (liia Agreement shall be
in writing and sha/l be delivered by nation/iify recognized ovcmighl delivery service, or by certified
msil until nottint receipt requested service, delivered to the address for the other parly set forth
below, or such changed uddrcss as shall hiive been provided by (he other party by a notice duly
given hereunder:
If to Company:

If to .Distributor:

11-

The Mntru Oroup, LLC
1 I 77 George Bush Boulevard
Suite No. 201
Dclray Beach, Florida 33483
I nnerlighi, Inc.
.867 East'2260 South
Provo, Utah 84606

Assignment of Agreement,

'Neither this Agreement nor any rights, duties Dr obligation* hereunder may be assigned by
Distributor without the prior written consent of Company, which may be .given or withheld in its
sole discretion.
12

Miscellaneous,

'This Agreement shall bt binding upon, and inure to the benefit of, the parties hereto and
their respective successors and assigns (provided hqwever, that nothing contained herein shall be
construed .as .authorizing any party to assigr\ any rights or instruments which it has agreed not lo
assign pursuant to provisions hereinabove contained). This Agreement constitutes the entire
agreement of the parlies with respect to the subject matter hereof and may not be amended or
modified except by a written instrument signed by each of the parties hereto, in (he event any party
oornmenacs cxry oction or proceeding lo enforce its rights hereunder, the prevailing pasty or parties
in any such action shall be entitled to recover all of their costs and expenses, including reasonable
attorneys fees, incurred in connection (herewith from the non-prcvaifing party or parties, both in
connection with the original action relating thereto and any and all appeals therefrom, No party
shall be construed as having waived any of its rights hereunder utfless such wniver shall be in
writing signed by the party agsinsl whom such waiver is being sought Neither the failure of any
party to exercise ajiy power given such party hcrrundcr or lo insist upon strict compliance by any
other party with its obligations hereunder, nor any custom or pnaciioc of ihc parlies at variance -with
the terms hereof, shall constitute u waiver of any party's right to demand exact compliance with the
terms hereof. This Agreement shall be construed and interpreted under (he laws of (he State of
Florida ajid the parties agree tlmt any action or proceeding brought concerning this Agreement may
be brought only in the courts of Polm Beach County, Florida, and each party hereto hereby consents
to the jurisdiction oTsuch courts The parties agree that this Agreement is the result of negotiation
by the parties, cech of whom WHS represented by counsel, and thus, this Agreement shall not be

^

[53

I

1A

06

B)/]C/}395

0 7: ] 7 a
BB:d5

Jaffee
C AMD 5 COMPUTERS

I2297779S2?

PAGC

£12

construed ngainsi the. drafter (hereof. No representations, inducements, promises or ngre-mncnls,
oral or otherwise, bclw&cn \hc parties not embodied herein or incorpornicd herein by reference shall
be of any force or cfTccl. Thii. Agreement m«y be executed in any number of counterparts, e/Lch of
which shall be deemed lo be an original, bui all of which, when taken together, .shall constitute but
one ajnd the same instrument. Ail references herein to the singular shall include plural and till
references herein to (be masculine gender ithall include Lhc feminine wd neuter genders, .and v'icv,
versa..
W WITNESS THEREOF, the panics hereto have executed this instrument as of the dale
first set forth above,
THE MATRIX GROUP, LLC

INNERLIGHT.INC.
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20978

The POnunibormusI appear DM nil related correspondence,
shipping papers, and invoices.

fRlMIJl

Phone 0 0 1 - 6 5 5 - 0 6 0 5

2260 S
UT 04606

Fax

801 - 6 5 5 - 0 6 2 2

SHIP TO
InnerLight inc.
867 E 2260 S
PROVO, UT 84606

7 George Bush Blvd #101
ray, FL 33482
Phone No:
Fax No:

(888) 862-3227
(561)330-7596

Vendor ID. No.

10,000

SHIP VIA

F.O.B. POINT

DISCOUNT

TERMS

WAREHOUSE

None
Kathy Christiansen

11/2004

QTY

622
REQUISITIONER

DATE

Phone (801) 65 5-0605

ITEM
510000

UNIT
PRICE

TOTAL
PRICE

7.8500

78,500.00

DESCRIPTION
510000: Skin-Deep OxyPlex

TM

TOTAL:

78,500.00

l. Please send two copies of your Invoice.
I

Enler this ordcrin accordance vrilh .ho prices, terms, delivery method
and specifications listed above.

3. Please nollfy us immediately II ya. arc unable to ship as specified.

4. Send invoice lo:
InnerLighllnc.
0C7E22G0S
Pro/o, UT M606
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Beverly Sassobri

" Beverly Sassoon

Healthy skin is essential to one's appearance. It
marks vitality, and allows a person to exude health
and energy. We searched through scores of
skincare options to create a skin restoration and
health program that could mimic what today's most
highly trained dermatologists and plastic surgeons
offer their patients - without our customers ever
having to set foot in a doctor's office.
DermaPiexTherapie is a program backed by
science and created by doctors - and proven to
work. It offers the synergy of the Rendon Rx
Therapeutic Skincare line, a dermatologist-created
exfoliating peel and skin maintenance system, and
the miracle of OxyPlex. a product used by
dermatologists and plastic surgeons worldwide to
speed skin restoration and enhance cosmetic
procedure results.
The six-week peel will help to revitalize worn, aged
and damaged skin; OxyPlex will rebuild cells by
delivering much-needed nutrients and oxygen and
reversing skin damage: and the maintenance
cleanser and creams will help keep skin looking
radiant and youthful.

The DermaPlex Therapie system is the only kit in the world that marries these two powerful skincare
products- and only doctors offered these individual programs in the past. Now they are available to you
in a comprehensive system that will not disrupt your life, but will restore your skin to its healthiest state.

Skin Deep OxyPlex* DermaPeel Complex* Day Creme with SPF2D
24-7 pHvdration Creme * pHaze i Cleanser* Rendon Complex

(

.A**,

W$™z%M
j <4 *• | | C | j 4- ) :;@hnp://vAvwJnn£rlightinc.com/hale/beveriysassoon/SI<inDeep.cr'rri

'"

"~ri

mm

BEVERLY
The Secret of Beautiful Skin
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Skin Deep OxyPlex with Pure Oxygen Clinically
proven, scientifically designed OxyPlex is a multinutrient oxygen treatment that is nothing short of
revolutionary. Recent studies published in the Journal
of Physiology reveal that the epidermis and dermis
receive oxygen from atmospheric air. which means
that the skin actually breathes. However, as our skin
ages : it loses its ability to retain adequate levels of
oxygen. By age 30. the ability for ceils to retain oxygen
decreases by almost 30 and by age 50. it decreases
by over 50 As the skin?s oxygen supply diminishes,
lines, wrinkles and dull or lifeless skin becomes more
pronounced. When we oxygenate our skin, we allow it
to breathe. The benefits of oxygen in promoting wound
repair and cellular renewal are well-documented. By
infusing pure oxygen into the skin, we can improve its
health and encourage the cells to purify, clarify, and
eliminate waste and toxins more quickly.
What are the benefits of pure oxygen for your skin?
•

Glowing Complexion

•

Cellular Repair

•

Collagen.Stimulation

•

Destruction of Bacteria

Reduced nutrition to the epidermis from aging is one factor that causes cellular exhaustion and
weakness. Without proper nutrition to the epidermis, cellular metabolism of the epidermal cell is
slowed. Furthermore, the transportation of certain unwanted byproducts of cellular metabolism, such as!
free radicals are reduced. This is an exceptional product benefit, as the accumulation of free radicals j T '
within the cell can lead to undesirable mutational damages in the cell and. ultimately, cancer. CxyPlex
is one of the few products in the world that has unlocked the secret of a successful oxygen deliver/
system, using pure oxygen.

Qinn n ^ n HYVPIPY • rwmaPAe! Comolex • Dav Creme with SPF 20_

"*

*~ 111 O \"i\ + I S © hiip:/7vAvw.innerlighiinc-com/hale./beverivsassoon/produas.cfm

Sj3|£|!|Kij^^

;py

3.EfflH;.

^r„

5 s J n :m U 11 '".t
;

I Dropped 31 Pounds in 31 daysK Steve Hale, 3 5 9-336-84 B 8

Qgc^Cocai,

skin

deep

OxyPiex™
WHEN Y O U LOOK G O O D ,
W E LOOK G O O D ,

with Amino-/Jit.w<io
an e v o l u t i o n In c e l l u l a r

rebirth

Board certified plastic surgeon
Michael F. McGuire, M.D,, F.A.C.S.,
has seen, firsthand, the skin
healing and rejuvenating powers
of OxyPlex rN .

11III
BEVERLY
SASSOON
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Dr, McGuire, an associate clinical
professor in the Department of
Plastic Surgery at UCLA and chief
• of plastic surgery a t St, John's
Hospital in Santa Monica, Calif,,
• has been using OxyPiex™ in
conjunction with peels and other
cosmetic procedures for years.
OxyPiex-1- is essential for
cellular rebirth.

lH^lllHII

mm

It is clinically proven to work at
: the cellular level to help patients'
skin heal at a significantly faster
rate dfter derma peels and other
cosmetic procedures,
The combination of the OxyPiex'"
with the Rendon Rx Complex®
makes the BEVERLY SASSOON
DermaPlex Therapie™ System
a truly revolutionary at-home
skincare product.
Let the power of OxyPiex'"
breath new life into your skin.
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OXYPLEX™ -CLINICALLY TESTED FOR SAFETY AND EFFECTIVENESS AT A MAJOR AMERICAN UNIVERSITY.
AND USED BY PLASTIC SURGEONS AND DERMATOLOGISTS WORLDWIDE WITH ASTOUNDING RESULTS.
OXYPLEX™ MULTI-NUTRIENT OXYGEN TREATMENT RESTORES WHAT TIME TAKES AWAY. OXYPLEX'"
^ . . ^ ^ C C D C rTRPAi/TJFUL. HEALTHY & YOUTHFUL.
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skin deep O x y P l e x m

the most advanced
topical treatment available
without a prescription

with Amino-Plex®
Plastic surgeons, dermatologists and other medical specialists have used
OxyPIex'"'1 for more than a decade to accelerate healing after cosmetic
procedures and to treat difficult-to-heal wounds.
In clinical studies (IRB approval) at a leading university, UCLA, O x y P l e x m
has been shown to reduce irritation and improve healing faster with better
results after the follov/ing procedures;
Laser H a i r R e m o v a l - loss

irritation

C h e m i c a l P e e l s - Faster healing, better result
Laser R e s u r f a c i n g - helps reduces recovery time, improves
M e d i c a l M i c r o d e r m a b r a s i o n - helps reduce irritation,

results

improves

resales

H a i r T r a n s p l a n t a t i o n - helps reduce irritation, improves sur\<ival rate
Rosacea - reduces redness, reduces irritation, improves skin quality
,-.:*._

1*-'"^ mrhim crarrinn. nromotes healing
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COMMENT
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•AMOUNT
3,162.40
19,661152

mfiownrr

0.00
0.00

NETAMfflfWT...
3,162,40
19,661.52'

^B^^dl3VG>^tyDDC0MEto!Tr«flIWTED.OW^»^EMJtrA^fHEtt

m

^EgTOgSfl^^

InnerLight Inc.
Phone: §01-655-0605

31^5

ZIQNS FIRST NATIONAL BANK
AMERICAN FORK OFFICE
609 E STATE RD AMERICAN FORK UT 34003

65116

1240

867 E 2260 S
Provo, UT 84606
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12/16/2004
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NATURAL BRONZE

F

RATABLE IN US FUNDS
ni
D

Four Thousand Seven Hundred Ninety-Four and 51/100*******************^^^

/ /

GULF STREAM BUILDING
2nd FLOOR, Suite 201
1177 GEORGE BUSH BLVD.
DELRAY BEACH, FL 33483
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INVOICE#1505
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InnerLight Inc.
Phone: $01-655-0605
867 E 2260 S
Provo, U T 84606
PAY
TO THE
ORDER
OF

NATURAL BRONZE

ZIONS FIRST NATIONAL BANK
AMERICAN FORK OFFICE

31-5
1240

65084

B09 E STATE RD AMERICAN FORK, UT B40D3

12/9/2004

**mfi$L5Q

PAYABLE IN US FUNDS
Ninety Thousarld Six Hundred Fifty-Two and 5Q/100****************************K *+****+*********»i«****************'i«*********
GULF STREAM BUILDING
2nd FLOOR, Suite 201
1177 GEORGE BUSH BLVD.
DELRAY BEACH, FL 33483

EMO:

INYOICE#1468

InnerLight Inc
Phone: §01-655-0605

ZIONS FIRST NATIONAL BAN
AMERICAN FORK OFFICE

65105

31-5
1240

609E STATE RD AMERICAN FORK UT 04003

867 E 2260 S
Provo, UT 84606

12/9/2004

NATURAL BRONZE

^ **lGf 535,25 '
PAYABLE IN US FUNDS

Fhousand Five Hundred Thirty-Five and 25/lOG*****^***^*^^***^*-************-*1**'**'^**^*****-*''* ***+************#********** .
'
Dollars

J/

GULF STREAM BUILDING
2nd FLOOR, Suite 201
1177 GEORGE BUSH BLVD
DELRAY BEACH, FL 33483
/
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InnerLight Inc.
Phone: §01-655-0605

ZIONS FIRST NATIONAL BANK
AMERICAN FORK OFFICE

3h5

65086

1240

608 £ STATE RD AMERICAN FORK, UT 84003

867 E 2260 S
Provo, UT 84606
•AY
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12/9/2004

**2&,5l4r30

NATURAL BRONZE
^ \ ^ -

PAYABLE IN US FUNDS

Twenty Thousand Five Hundred Fourteen and 30/1QO***********************^^
GULF STREAlyl BUILDING
2nd FLOOR, Suite 201
1177 GEORGE BUSH BLVD
DELRAY BEACH, FL 33483
EMO:
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InnerLight Inc.
Phone: §01-655-0605
867 E 2260 S
Provo, UT 84606
PAY
TO THE
ORDER
OF

ZIONS FIRST NATIONAL BANK
AMERICAN FORK OFFICE
609 E STATE RD AMERICAN FORK UT 84003

31-5
1240

65087
12/9/2004

NATURAL BRONZE

**23,tfi?.7$
PAYABLE IN US FUNDS

Twenty-Three Thousand One Hundred Sixtv-Six and 75/100**************************************^

/

GULF STREAM BUILDING
2nd FLOOR, Suite 201
1177 GEORGE BUSH BLVD \
DELRAY BEACH, FL 33483 ^
4EMO :

INVOICE// 1467

/^^y^0^/

Dollars
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IniierLieht Inc
Phone §01-655-0605

867 E 2260 S
Pxovo UT 84606

ZIOWS FIRST WATIOUAI ftAUf
AMERICAN F O R r O F F i C E
SOD E STATE RD AMERJCAW FORK UT 04003
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1 J/1/2004
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NATURAL BRONZE
One Thousand One Hundred F i t y - F i v e dnd 497] 00******

*WW,*^u^„„„„„+„M,^^+^^^^^^
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PAYABLE IN US

Dollars

GULF STREAM BUILDING
2nd FLOOR, Suite 201
1177 GEORGE BUSH BLVD
DELRAY BEACH, FL 334E3
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InnerLight Inc
Phone; !oi~655~Q605

ZIONS FIRST NATIONAL BANK
AMERICAN FORK OFFICE

64905

31-5
1240

609 E STATE RD AMERICAN FORK UTB40O3

867 E 2260 S
Provo, U T 84606

11/5/2004

i
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NATURAL BRONZE

Three Thousand Eight Hundred Eighty-Four and 0 0 / 1 0 0 * * * * * *

PAYABLE IN US FUNDS

Dollars

:M*********************+*******<

GULF S T R E A M B U I L D I N G
2nd FLOOR, Suite'201
,

1177 G E O R G E B U S H B L V D
DELRAY BEACH, FL 33483
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InnerLight Inc
Phone: $01-655-0605

ZIOUS FIRST MATI ONAL BANK
AMERICAN FORK 0FFJCE

64910

31-5
1240

609 E STATE W AMERICAN FORK, UT 84003

867 E 2260 S
Provo, U T 84606
>AY
TO THE
DRDER

NATURAL BRONZE

3F
T w o Thousand Fifty-Seven and Q 0 / 1 Q O * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *

11/5/2004

*%0*?89
PAYABLE IN US FUNDS
* * * * * * * * * * * *****3*J(

Dollars

GULF S T R E A M B U I L D I N G
2nd FLOOR, Suite 2 0 1
1177 G E O R G E B U S H B L V D
DELRAY B E ^ C H , FL 33483
[EMO:
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InnerLight Inc
Phone; §01-655-0605

ZIONS FIRST NATIONAL
AMERICAN FORK OFFICE

31 5
1240

«£

6Q9 E STATE RD AMERICAN FORK UT 84003

867 E 2260 S
Provo, UT 84606
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64868
10/31/2004

* **3>548 n

NATURAL BRONZE

PAYABLE I N US FUNDS

liree Thousand Five Hundred Forty-Eight and 30/100*^**^****************** + ^ + * + * + ^***/ i

***** + *********-£***********=»

// /

Dollars

GULF STREAM BUILDING
2nd FLOOR, Suite 201
1177 GEORGE BUSH BLVD
DELRAY BEACH, FL 33483
40:

INVOICED 1445

raa^OTWffmm^^

a$&"QttlGlNAl&T3d"(SD

InnerLight Inc.
Phone; §01-655-0605

31-5
1240

ZIONS FIRST NATIONAL BANK
AMERICAN FORK OFFICE
609 E STATE RO AMERICAN FORK UT 84003

867 E 2260 S
Prava, UT 84606
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64865
10/31/2004

z1- *mj$mm

NATURAL BRONZE

PAYABLE I N US FUNDS

Seventy-Eight Thousand Five Hundred and 00/100***************************^^
GULF STREAM BUILDING
2nd FLOOR, Suite 201
1177 GEORGE BUSH BLVD
DELRAY BEACH, FL 33483
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InnerLight Inc.
Phone: 301-655-0605
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ZIONS FIRST NATIONAL BANK
AMERICAN FORK OFFICE

31-5
1240

64864 '

609 E STATE RD AMERICAN FORK UT 84003

867 E 2260 S
Provo, UT 84606

NATURAL BRONZE

JO/31/2004

**354785>9Q
PAYABLE IN US FUNDS

Thirty-Five Thousand Seven Hundred Eighty Five and 90/100***********************4

( < * * * * * ******************

Dollars
GULF STREAM BUILDING
2nd FLOOR, Suite 201
1177 GEORGE BUSH BLVD
DELRAY B^ACH, FL 33483
EMO:
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20CK3E OAKLAND PARK BHffll
FORTUUDER0ALEj|Fir
(954) 563^fl4$V'"

0060079
BQNQDY

DAT£ r £ 9 SEP
hAOE: 03

04

THAWK|VQU ran FAvoawG- w vi/ir^i

1177 GEORGE BUGH KL UD
SUITE 2 0 1
DCLRAY
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FQR ALL TICKETS !$SUGDi W£ fll'
ROEIVlNfrPAVMENrfOR YDJI&TI

33t9D

PLEASE RFMCT FROM THLjji

FOR:

BASbOON/UEVEKlV
LODGING

DEALS

l^TUUTlPi
Alf*

=
FRIDAY
AMERICA W t ^ T

LV LOS ANGELES
DEPART: TERMINAL
AR I AS VEDAS

FIRST

FLT ; B 7 3

OCf
AJL

MCD

04-

VACATIONS

CLASS
EQP :

I

SUNDAY
Fl T : i 0 M
AMI * EC ft WEDT
L V L A S VEGAS
D E P A R T " MAIN TERMINAL
AR LOS ANGELES
A R R I V E : TEPfUNAL
1
SEAT 0A
XD815B000991
BILLED

fciUETNO

737

300

3?fl IN
NON-STOP

124 4 P

AKK1VE2 MAIN TEKNINftL
&EAT BC
HOTEL L A S VEGAS
HANDALAY BAY RESORT
MANDALAY BAY FfESOKT AMD CASINO
3 9 3 0 L A S VEOAS HLVD SOUTH
L A 5 VtVftS
WV 6 ? i t ?
PONE 7 0 f ? ~ 6 3 d ~ 7 7 7 7
FAA'
70S- 6 3 2 - 7 2 3 4
OUAkANTEED L A T E A R R I V A L
C O N F I R M A T I O N QJONQF
NQN S?1OKTN0 KING
17

CRWSES

0 U T - 3 7OCT
I
5 NIGHTS
'
i ROOM
D E L U X E , J KING BED
l < A T E - B ? 9 . . # 0 U S B FEft N1BHT
CANCEL 4 8 HOURS P k 10K' T 0 A R R I V A L
MANDALAY BAY S P E C I A L RATES

FIRST
V0JP

CLASS

lfi0P

I CIP : A I l l ^ U G
0 1HK 17M1N
NON-3T0F

TD AX37P7G3<fnU30 L 0 7 6

TOTAL BASE
ItJTAL TAX
WET CC B I L L 1NG

TOTAL AMOUNT DUL

A320

£5,00*
2 5 . 09
0- « 0 i

as,
0.
i

THhNKS, FOK
i'PA

f R A Y M TNG u l I W

i
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<\ ni/tnm
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561

Catinella

8v

381S

p. 4

Page I of 1

s

rus&o

From:
To:
Sent;
Subject:

"America West Airlines" <hpagentlink.reservations@americawest.com>
<suerusso@belisouth.net>
Wednesday, September 29, 2004 12:14 PM
America West Confirmation -UEGFGL

^ i

AiRLiHEi'

Corifirrnalioii

ifc *«»£&,
•' K•j^,lStA^^a^i:,^Mi\iy•:

INNOVATIVE
TVL 5VCS

C o n f i r m a t i o n ~ UEGFGL
Thank you for flying America West. Your purchase is now complete and your reservation has
been electronically ticketed. No paper tickets will be sent.

OINA LAMBORGHINI
(954) 563-5996
Confirmation

UEGFGL

Date-issued

09/29/04 at 09:10 AM

Form of Payment

American Express •*•*•"-** *1076

Grand Total

3326.70

BM to

BEVERLY SASSQON

Agency

INNOVATIVE TVL SVCS

Agent

DINA LAMBORGHINI

Passenger Information
Party of \
Frequent Flyer #
BEVERLY SASSOON
Special Needs
Passenger
JD&p3rt
111:45 AM
Fri. Oct 15
12:03 PM
Sun, Oct 17

Right*
073

104

Ticket #
401J576O32B420

Seals
2C.2A

Special Needs
From
Los AngoJcs, CA
Boeing 737-300

To
Lqs Vegas, NV

Arrive
12:44 P M
Frt. Oct 15

Las Vegas, NV
Airbus A320

Los Angeles, CA

01:20 PM
Meat:
Sun, Ooi 17 Class: First |

1 Pas3enger(s)
Fare
Taxes £ Fees

Details
Moal:
Class: First

5286.52
S-^0.18

$325.70

Grand T q t a l
T e r m s and Conditions

Tickel is non-lransteroblc
Tickel expires one year horn date o/ issue
Tills ticks', is non-refundable. Any change to this reservation {including (light, dales, or cities) is
subjec' to a $100 change fee per passenger. The new itinerary/ will be pnced Bt the lowest
oveitoble published (ore at [he lime of change, which may result in a fare increase.
Travef is valid en AmeriCD West or America West Express only

9/29/2004
uMit? r.m nil

n,*-<r"?K c\c\ t\

nnw
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Catinella

1 0 / 2 J / 2 0 0 4 1(1:04 FAX 702G327273

56 1

JBANfJAUSr

.•».

•.*•••'

KAY

v
('

.

8 0 16

A/R

S)D02

to.
C
y

MANDALAY BAY

Rworvationa

Guest Information
I-70X132-7777
FAX I -703.632.7£W

TTV 877*432-710 J

39SO Las Vagus Blvd. South /Las
tiamc
Addrtu

Vagust Ncwda
Rxto
lUom
Arrive

BEVERLY SA5SOQN

Dtp4rt

89119

MB
24122
10/15/04
10/17/04

Person*
1
Deposit AmavnC
Corapaoy N'aiuc

**SABRE*-*

Group Code PPLEQDS
Trove* Agwf No.
Recv No

ThanJt you for staying with us
DATE
REFERENCE
DESCRIPTION
10/15/04 382749002144 ROOM CHARGE MB24122
TAX
10/15/04 382745150.948 APPLIED DEPOSIT
JOOXXX3CXXXXXX4 o Q 5
10/15/04 382745156073 ROOM SERVICE
20/16/04 382759002234 ROOtf CHARGE MB24122
TAX
10/16/04 382755205532 ROOT SERVICE
1O/1B/04 3G2755241376 IN ROOM BOTTLED WATER
10/17/04 3B2765295277 ROOM SERVICE
10/17/04 3 82765321219 FRONT DESK AMERICAN EXP
XXXXXXX30CXXXX3 056

CWiRGES'
289 .00
25 . 0 1
315 . 0 1 -

Page
1
3S249iG5i:jl2

BALANCE

23 .16
2 9 9 , .00
2 6 , ,91
10. 55
5 , 32
16. 25
381, 5 3 ^

TWAK'K T?OW FG-'R STAYfWG AT IWaM»ALftV SAY
,00
J»gr*al»>K. rrrwj^jkJJyDiililt.Wlbc loVJrtJrnJ |«TTOU, AIM. *r j«q»*n»lJrj» fall Is p%p p«y «>rik<cl>q>Gi: HultoO, H> k*vr jOUbffl »«/*ic»t*ic4
m<K<<»rJ J*«it»»t*»Tf»U Wj«i|* lo diM-^ JttftuI tm «lntV-*ML Tic U*tuiti*y CUy IUaorlA O i l no asniittts »> mpwu4b»*r Rx
r«t*>cy or-vnWI<Vu oMcWjh^Wai to r»raiMydrpnjolbo>a, wWck nrrpr»>lijf« nhxmt rAit-pciM Ibt tjAno ftp,

Guest Card
MANDALAY SAY

Guest Card
MANDALAY BAY

* , . v . i v C.......

Arrival Date

R « . NO.

Arrival Date

Km. /No.

D e p a r t u r e U«tc

ClicdcOu(H?00jiai

Departure D*k

CimckOui M:0Q*»i

Signature

5l£«aiurt
v\uu(xiLYvnw<s{(zmi.

nxrovsoroxDefAirrunc

VAUDONLYWllX*MlCXKl>. HJtflXrS UfOrt SO-ARI URC

RicK

Catinella

56 1 &

aai G

Invoice
Natural Bronze-Matrix
1177 George Bush Blvd.
Suite #201
DcLray Beach, FL 33483

nr.

! «

n"'-'

TabF

Matrix Groitp LLC
1355 V/est Palmetlo Park Road
Suite #348
Boca Raton, FL 33486

|

D ^

\

Invoice #
IS07

i/2/72005

am To
Inricdigh;
JCatby Christiansen
867 h 2260 S
Pruvo, UT W606

P.O No.

Project

Terms
Due on receipt

Quantity

•Gsscript!qn
Beverly Sassoan Appezmncc Fec-Pcr Contract
Newark, New Jersey March llfhand i2tti, 2005

Amount

Rate
2.500.00

Total

2.500 U0

52,500.00

1

Payment History

Customer:J...
Date Race;..,

(nncrLighl Inc
04/04/2005

10/25/2006

Payment M...

Goes* Mo

Payment A,..

Z500 00

Memo

jnyotces Paid, Statement Charges Paid and Payment Deposit
Type
invoice

Date
03/21/200

/^

fjumber

Amount
*2,500 00

Prnt Balance
0.00

TabG

))
] 4 OG 0 7 : 3 9 a
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News Releases 1 Events & Trade shows

Press Releases
Contact:
David K. Waldman/John W. Heiishorn
Lippert Heiishorn & Associates
(212) 838-3777
dwaldrnan@lhai.com

The Ouigley Corporation
Carl Fonash
Shareholder Relations
(267) 880-1111

The Quigley Corporation Announces Launch of BEVERLY SASSOOhl
Product Line by Its InnerLight Subsidiary
DOYLESTOWN, PA. - November 3,.2004 • The Quigley Corporation (Nasdaq:
QGLY) today announced that InnerLight, Inc., a wholly-owned subsidiary within the
company's Health and Wellness Segment, has secured Beverly Sassoon as a
spokesperson and launched an exclusive skin care line under the BEVERLY
SASSOON brand name.
The BEVERLY SASSOON skin care line has been created and endorsed by Marta
Rendon, M.D., President-Elect of the American Academy of Dermatology as well as
Michael F. McGuire, M.D., F.A.C.S., a board certified faculty member at the UCLA
Medical Center in Los Angeles,
Stephanie McAnaly, President of InnerLight, said, "Beverly Sassoon's decades of
experience in beauty care products, as well as her celebrity status, are a perfect fit for
ihese revolutionary tested skin-care products. InnerLight is thrilled to market the
BEVERLY SASSOON skin care brand."
The BEVERLY SASSOON exclusive skin care products are ail tested by the Doctors
who developed them. The line of products is available in (he BEVERLY SASSOON
Dermaplex Therapie Kll. The Kit includes the DermaPeel complex facial peel system,
as well as OxyPlex, a soothing agent shown in testing to reduce the recovery time
from skin treatments. Together, these doctor-developed cosmeceuticals provide a
safe, at home, skin-care system that can provide the same results as costly
treatments. Also available in the kil is the BEVERLY SASSOON Day Creme and 24-7
pHydration Night Cream, with patented Rendon Rx Complex. Each ol the BEVERLY
SASSOON products available in the kit can also be purchased separately.
The Quigley Corporation (Nasdaq: QGLY, htlp.7/www.Quigleyco.com) is a leading
developer and marketer of diversified health products including {he COLD-EEZE®
family ol patented zinc gluconate glycine (ZIGG™) lozenges and sugar free tablets. In
September of 2004, The Company has also formed a wholly owned subsidiary,
Quigley Manufacturing, Inc with the acquisition of two FDA approved facilities to
manufacture its COLD- EEZE® branded lozenges InnerLight. Inc., a wholly owned
subsidiary, was formed in January 2001 for the purpose of introducing new products tc
-i^hi r -,r.e through a network of maepentienl distributors In addition to
^ ~ ^omnanv has formed Ouigley Pharma inc.

teyc;o.corc)/nowi,7niM
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News & Events :
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(http://www QuigleyPharma.com), a wholly owned ethical pharmaceutical subsidiary,
to introduce a line of naturally derived palented prescription drugs The Quigley
Corporation's cuslomers include leading national wholesalers and distributors, as well
as independent and chain food, drug and mass merchandise stores and pharmacies.
Certain statements in this press release are "forward-looking statements" within the
meaning of the Private Securities Litigation Reform Ac! of 1995 and involve known and
unknown risk, uncertainties and othef factors that may cause the company's actual
performance or achievements to be materially different from the results, performance
or achievements expressed o\ implied by the forward-looking statement. Factors that
impaci such forward-looking statements include, among others, changes in worldwide
general economic conditions, changes in interest rates, government regulations, and
worldwide competition.

Home | About Us ) Investor Relations | Business Units | News & Events | Contact Us
Copyright © 2004 The Quigley Corporation All lights reserved.

, deyco.com/news/nr/1 10304.{Jlip

Phone: (215)345-0919
Fax: (215)345-5920
www quiqleyco com

Putting the Care in Health

UJ

Unique and Diversified Healthcare Opportunity

>

Snapshot
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February 25,2005

The Quigley Corporation develops and markets diversified healthcare products. For nearly a decade,
the Company has been developing, manufacturing, and marketing its proprietary Cold-Eeze® family
of patented zinc gluconate glycine (ZIGG™) cold-remedy lozenge products. It has also developed a
variety of product extensions, which include Cold-Eeze Sugar Free Tablets, Cold-Eeze® Lozenge
Honey Lemon Flavor, Cold-Eeze® Green Tea with Honey, Cold-Eeze® Bubble Gum, and ColdEeze Spearmint Gum. The Company has also launched Kidz-Eeze™ Sore Throat Pops. In January
of 2001, the Company established an ethical pharmaceutical segment, Quigley Pharma, to diversify
by gaining entry into the prescription drug market, and ensure safe and effective distribution of any
potential new products. Quigley Pharma addresses medical conditions that may be overlooked by
large capitalization pharmaceutical companies. Prior to the creation o f Quigley Pharma, the
Company founded Darius International Inc., which specializes in introducing proprietary products
(specifically health and wellness products) into the marketplace through a network of independent
representatives.

Recent Financial Data
Ticker (Exchange)

QGLY (NASDAQ)

Recent Price (02/25/05)

$8.25

52-Week Range

$6.92410.63

Shares Outstanding

11.7 million

Market Cap. (mm)

$96.0

Average 3-month vol.

12,151

QUIGLEY CORP
as of 23-Feb-2005
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Insider+5% Owners

34.5%

Institutional Owners

2.0%

LOO

EPS (as of 12/30/04)

$0.03

50

Employees

131
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The Quigley Corporation's Cold-Eeze product is the only such cold product available with the patented
ZIGG™ formulation, clinically proven effective in two studies for reducing the duration and severity of
common cold symptoms by 42%. Cold-Eeze® has national distribution throughout the U.S. in wellknown drug and mass merchandise stores and pharmacies such as Wal-Mart, Target, Walgreens, CVS
Corp., Sam's Club, and Costco, among others.
Quigley Pharma is developing a diversified pipeline of compounds including but not limited to (1) QR333 for diabetic peripheral neuropathy, for which the compound is undergoing a series of toxicity
studies to support the safety of this naturally-derived compound prior to beginning a human Phase UB
dose ranging study; (2) QR-336 for systemic radiation, for which encouraging results were seen in a
preliminary non-Good Laboratory Practices (GLP) animal study of this naturally-derived radio protective
compound against ionizing radiation; (3) QR-435 for influenza, which has demonstrated efficacy in
significantly reducing the severity of illness in ferrets infected with the influenza A virus; and (4) QR-440,
a naturally-derived compound developed to treat arthritis and related inflammatory disorders.
For QR-435, Quigley Pharma is considering initiation of a Phase II Proof of Concept human clinical trial
in Europe, or in Israel, and may undertake further animal model studies to determine if the formulation is
•• . .- r_ u^s + r Q Q i m o n f n f p H r j i t i n n a j i nc ji ca ti 0 ns, including severe acute respiratory syndrome

PimuiK ttie Cate in tlealih

02/24/2005—The Quigley Corporation reported net sales of $17.8 million, an increase of 8.3%, for the
fourth quarter ended December 31, 2004, compared to $16.4 million reported for the same period in
2003. For the year ended December 31, 2004, net sales were $43.9 million, an increase of 5.9%,
compared to $41.5 million in 2003.
01/24/2005—Announced a research and development update for its wholly-owned Quigley Pharma
(Ethical Pharmaceuticals) subsidiary, which is developing natural-source prescription medicinals for
Influenza A, radiation dermatitis, and diabetic neuropathy.
12/20/2004—Announced that Doctors Mark Lebwohl and Phillip A. Low have been appointed to the
scientific advisory board of Quigley Pharma, Inc.
11/05/2004—In response to news reports citing a lawsuit filed in Bucks County, PA, by eight consumers
who are taking legal action against The Quigley Corporation, company officials said they had no
knowledge of the lawsuit until a faxed complaint was received at 2:15 PM EST on November 5, 2004. The
Company has yet to be officially served, and upon a cursory look at the faxed documents, the company
considers the suit to be frivolous and without merit, and will defend it vigorously. T h e company reaffirmed
the safety of its Nasal Spray due to completion of clinical safety studies conducted prior to retail
introduction in September of 2003.
11/03/2004—Announced that InnerLight, Inc., a wholly-owned subsidiary within the company's Health and
Wellness Segment, had secured Beverly Sassoon as a spokesperson and launched an exclusive skin
care line under the BEVERLY SASSOON brand name.
10/28/2004—Reported third quarter financial results. Net sales for the third quarter of 2004 were $9.7
million compared to $9.9 million reported for the same period in 2003. For the nine-months ended
September 30, 2004, net sales were $26.2 million, compared to $25.1 million in 2003.
10/13/2004—An 8-K filed with the SEC on September 13, 2004 stated that T h e Quigley Corporation
notified its customers of its decision to discontinue the Cold-Eeze® Cold Remedy Nasal Spray product
within its line of cold remedy products. The decision was made because the product has not developed
into a viable entry in the nasal spray cold remedy category. Since its launch approximately one year ago,
the product has not met either the Company's sales expectations or its return on investment projections.
Based on the Company's preliminary estimates, the discontinuation of the nasal spray product will result
in an approximately $422,000 write-off of inventory and an approximately $974,000 charge to net sales
resulting from anticipated customer returns of the product. As a result of all charges, the Company's
results for the third quarter will be adversely impacted by approximately $1,361,000. At this time, the
Company does not anticipate any additional future charges.
10/12/2004—Announced that the U.S. Patent and Trademark Office has approved the issuance of a
patent for the company's QR-440, filed on April 23, 2003, for a naturally-derived compound developed for
the treatment of arthritis and related inflammatory disorders. The company is preparing to begin
preclinical testing, leading to a submission of an Investigational New Drug application to the U.S. FDA for
potential approval as a prescription drug.
10/05/2004—Announced the completion of the asset purchase with JOEL, Inc., as announced on August
20, 2004, for approximately $5.1 million, which includes $4.1 million in cash and $1.0 million of the
Company's stock. The transfer of assets includes inventory, as well as land, buildings, machinery and
equipment of two manufacturing facilities, located in Lebanon and Elizabethtown, Pennsylvania. JOEL,
Inc. has been the exclusive manufacturer of the Company's Cold-Eeze® Lozenge since its launch in 1995.
08/20/2004—Signed an asset purchase and sale agreement with JOEL, Inc. for $5.1 million, which
includes $4.1 million in cash and $1,0 million of the Company's stock.
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Quigley Increases Revenues for the Fourth Quarter and Fiscal Year
- Profitability Continues in 2004 while Investing $3.2 Million in R&D DOYLESTOWN, Pa., Feb. 24 /PRNewswire-FirstCall/ — The Quigley Corporation
(Nasdaq: QGLY) today reported net sales of $17.8 million, an increase of 8.3%,
for the fourth quarter ended December 31, 2004, compared to $16.4 million
reported for the same period in 2003. For the year ended December 31, 2004,
net sales were $43.9 million, an increase of 5.9%, compared to $41.5 million
in 2003.
Net sales of the Company's Cold Remedy segment increased 10.1% for the
fourth quarter of 2004 as compared to 2003. Net sales of the Health and
Wellness segment decreased 9.4% during the quarter, due to a decline in the
number of active domestic independent representatives, which was partially
offset by an increase of 14.1% in this segment's European sales as compared to
2003.
The increase in net sales for the year ended December 31, 2 004 reflects an
11.5% increase in the Company's Cold Remedy segment and also reflects a 3,2%
decrease in net sales for the Health and Wellness segment, which were offset
by this segment's gains in international distribution of 135.4%. Even though
the incidence of colds during 2004 were fewer than the previous year, the
Company's Cold Remedy net sales increase for the year ended December 31, 2 004
reflects the success of expanded targeted advertising, marketing initiatives
and new product extensions of COLD-EEZE(R), which have generated greater
consumer awareness and purchasing of our products.
Net income for the fourth quarter ended December 31, 2004 was $2.0
million, or $0.13 per share, compared to net income of $2.5 million, or $0.17
per share, for the same period last year. Net income for the year ended
December 31, 2004 was $453,000, or $0.03 per share, compared to a net income
of $675,000, or $0.05 per share, for the same period last year • During the
fourth quarter and year ended December 31, 2004, the Company incurred research
and development costs of $837,000 and $3.2 million, respectively, as compared
to $766,000 and $3,4 million, for the comparable periods of 2003.
Additionally, net income margins by segments for the year 2004 are relatively
consistent with net income margins attained in 2003.
Gross profit margins for the quarter and year ended December 31, 2004
remained relatively unchanged as compared with the same periods last year. Net
income for the fourth quarter and year ended December 31, 2004 were primarily
driven by profit gains from fhe increased sales, which were offset by an
increase of $1.0 million in advertising costs. The fiscal year results were
also affected by a $178,000 increase in other income, which was offset by a
charge to gross profit margins of $1.4 million, or $0.09 per share, related to
the discontinuation of the Company's COLD-EEZE(R) Cold Remedy Nasal Spray
product. This charge includes a $672,000 write-off of nasal spray inventory
and a $680,000 reduction to net sales resulting from anticipated customer
returns of the product.
No tax or tax benefits to reduce income or losses are provided for the
quarters and year ended December 31, 2004 and 2003, since the Company is in a
net operating loss carry-forward position, which is from the cumulative effect
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of deducbions attributed to options, warrants and unrestricted stock from
previous years' taxable income.
On October 1, 2004, the Company acquired the assets of JoEL, Inc.,
encompassing inventory, land, buildings, machinery and equipment of two
manufacturing facilities, located in Lebanon and Elizabethtown, Pennsylvania
for approximately $5.1 million. The facilities are FDA approved and 'have been
the exclusive manufacturing sites of the Company's COLD-EEZE(R) lozenge since
its launch in 1995- The purchase of the manufacturing facilities allowed for
the establishment of Quigley Manufacturing Inc • , which protects the
proprietary manufacturing process of COLD-EEZE(R) and is anticipated to
improve cost efficiencies as volume production increases and allow for the
manufacture of other brands.
Guy J, Quigley, Chairman, President and Chief Executive Officer stated,
"We are pleased with our results for 2004 which reflect increased sales of our
core products and greater market penetration of our COLD-EEZE(R) Cold Remedy
products which enabled us to further fund pharmaceutical research and
development. In addition to increasing annual revenue, gross margins for the
year would have increased without the previously mentioned $1.4 million
one-time costs associated with a product discontinuation.
"We expect that our recently introduced new or improved products including
COLD-EEZE(R) Bubble Gum and COLD-EEZE(R) 'Green-Tea with honey' lozenges will
garner greater consumer acceptance and enhance product sales. We will continue
to develop products that appeal to adults as well as a younger demographic,
which could represent a significant opportunity for expansion in market v-^____
penetration and future growth.
~~
"The main core of our Health and Wellness Company, our Supergreens (TM)
line of products developed by Dr, Robert 0. and Shelley Redford Young,
continues to move forward with loyal distributors. The Company is also excited
by the launch of an exclusive skin care line under the BEVKR'LTT SASSOON"brand
name to diversify trfris" segment's product offerings.
"We also remain focused on expanding our wholly-owned Ethical
i_
_
Pharmaceuticals subsidiary, Quigley Pharma, which is developing natural-source
prescription medicinals for Diabetic Neuropathy, Systemic Radiation, Influenza
A, and Rheumatoid Arthritis. We continue moving forward with our development
and testing phases of ethical pharmaceutical drugs and are confident that this
segment of our business will be a source of future growth for the Company,"
concluded Mr. Quigley.
The following is a list of formulations currently in the Quigley Pharm
pipeline and an update on their progress:
Diabetic Neuropathy -- QR 333: Per the FDA's instructions at the last
Pre-IND Meeting for the continued development of this drug; the compound is
undergoing a series of toxicity studies to support the safety of this
naturally derived compound for the relief of symptoms of diabetic peripheral
neuropathy, prior to beginning a human Phase IIB dose ranging study. The
company expects the toxicity studies to be completed by June 2 0 05. The
company hopes to begin pivotal studies on this compound in 20 0 5 .
Systemic Radiation — QR336: There were encouraging results seen in a
preliminary non-GLP animal study of this naturally derived radio protective
compound against ionizing radiation; A pre-IND meeting was held at the FDA in
October of 2004 with the Division of Medical Imaging and Radiopharmaceutical
Drug Products. A GLP controlled animal study of the QR 336 formulation for the
Radioprotection/Treatment of Radiation Lethality Induced by Four MeV Photons
in the C3H Mouse will begin this year after a short series of experiments to
further define the compound's method of action.
Influenza A — QR435: Retroscreen LTD. at The University of London has
started a final animal model influenza study in preparation for a proposed
human Proof Of Concept Study to start in mid-2005. The study "Prophylactic
-^•hon-Mal of different QR-435 antiviral nasal spray formulations
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David L Arnngton (4267;
Matthew (\. Grinimei (9692;

Fourth Judicial District Court
of Uteh County, State ©f uta'n

DURHAM. .IONICS & PINI-,GAK

I 11 East Broadway. Suile 900
Post Office Box 4050
Sail LakeCily. Utah 84 110-4050
Telephone. (KOI; A 15-3000

^iAl^J!^

Thomas J'.J. MacAniff
PA Attorney J.D. No. 01895
Ursula J-J. Leo
PA Attorney i.D No. 91281
EASTBURN AND GRAY. P.C.
60 East Court Street
Doyleslown. PA 18901
Telephone (215; 345-7000
Attorneys foi Plaintiff lnnerhght, Inc.

IN THE FOURTH JUDICIAL DISTRICT COURT
UTAH COUNTY, STATE OF UTAH

INNERLIGHT. INC.,
Plaintiff,
vs.
THE MATRIX GROUP. LLC
Defendant.

ORDER (1) GRANTING
PLAINTIFF'S MOTION TO STRIKE
PORTIONS OF THE THIRD
AFFIDAVIT OF ANTHONY R.
CANTINELLA
AND
(2) DENYING DEFENDANT'S
MOTION TO STRIKE PORTIONS OF
TATE'S AFFIDAVIT

CiviJ No. 060400775

.1 ud<ie Fred D Howard

Defendant The Matrix Group. LLC ("Matrix";, hied iLs Motion lo Strike Portions of
Tate's Affidavit. Plainliff. inncrlighl. inc. ("lnnerhght"; moved to strike paragraphs 3. 6-14 and
Exhibits A & B of the Third Affidavit of Anthony R CantinelJa. Matrix filed this affidavit after
^^r

.Deputy

Innerhghfs bnefrng had closed along with Matrix's reply memorandum in support of Matrix's
motion foi summary judgment These motions came on foi on January 17. 2007. in conjunction
vvilh the parties' cross motions loi summary judgment. David L Arlington and Matthew G.
Gnmmei appeared loi Plaintiff. Jnneiiight Jnc Stephen Quesenberry and CharJes L Persehon
appeared ioi Defendant. Matrix. The parties agreed to submit both motions
Having studied the motions, authorities and affidavits, the Court ORDERS AS
FOLLOWS:
L

Plaintiff Jnnerlight lnc.\s Motion to Strike Portions of the Third Affidavit of

Anthony R. Canlinella, which was unopposed, is GRANTED.
2.

Defendant The Matrix Group. LLC's Motion to Strike Portions of Tate's

Affidavit is DENIED.

Dated

/^g^f

#

• 2007.

BY THE COURT

^L^JL^O

APPROVED AS TO FORM

Stephen Quesenberry
Charles L. Perschon
Attorneys for The Matn> Group, LLC1

—
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Fourth Judicial District Court
of Utah County., State of Utah
f /2£? OC,

.feft[ ..Deputy

4TH DISTRICT COURT - PROVO
UTAH COUNTY, STATE OF UTAH
NOTICE OF
ORAL ARGUMENT

INNERLIGHT INC,
Plaintiff,

vs .

Case No: 060400775 CN

THE MATRIX GROUP,
Defendant,

Judge:
Date:

FRED D HOWARD
November 2 8,2006

ORAL ARGUMENT is scheduled.
Date: 01/17/2007
Time: 10:30 a.m.
Location: Second Floor, Rm 202
FOURTH DISTRICT COURT
125 N 100 W
PROVO, UT 84601
Before Judge: FRED D HOWARD
The Court has set aside 90 minutes to hear oral argument on the
following motions:
1.

Innerlight's Motion for Summary Judgment

2.

Defendant's Motion for Summary Judgment

3.

Defendant's Motion to Strike Portions of Tate's Affidavit

Dated this

"2Kg day of

iJweMbv.r-

2 0 &C •

U.

A./I,

a.

District Court Deputy Clerk

Case No: 060400775
Date:
Nov 28, 2006
The Court will provide interpreters for criminal cases and domestic
violence cases involving protective orders or stalking injunctions.
(Fees in criminal cases may be imposed at the judge's discretion.)
IF YOU NEED AN INTERPRETER IN A CRIMINAL CASE OR DOMESTIC VIOLENCE
CASE PLEASE NOTIFY THE COURT at (801)429-1006 (five days before the
hearing, if possible) .
FOR ALL OTHER CASES, you must bring someone with you to
interpret. If you do not know someone who can help you, the names
of court interpreters you can hire are listed on the courts'
website at http: //www. utcourts . gov/resources/interp/certif ied. htm.
If you do not have access to the internet, ask the court clerk to
print off a copy of this list for you.
In compliance with the Americans with Disabilities Act, individuals
needing special accommodations (including auxiliary communicative
aids and services) should call TERI at (801)429-1112 at least three
working days prior to the proceeding. (For TTY service call Utah
Relay at 1-800-346-4128 or 711)

Case No: 060400775
Date:
Nov 28, 2006
CERTIFICATE OF NOTIFICATION
I certify that a copy of the attached document was sent to the
following people for case 060400775 by the method and on the date
specified.
METHOD
Mail

Mail

Mail

Dated this

Z%

day of

/'J<WVlK->

NAME
THOMAS F J MACANIFF
OTHER PARTY
60 EAST COURT STREET
DOYLESTOWN, PA 18901
DAVID L ARRINGTON
ATTORNEY PLA
111 E BROADWAY STE 90 0
SALT LAKE CITY UT 84111
STEPHEN QUESENBERRY
ATTORNEY DEF
3319 N UNIVERSITY AVE
PROVO UT 84604
20 flC

Deputy Court Clerk

